MDT
88.96
+0.59%↑
VEEV
226.47
-0.52%↓
A
115.98
+2.05%↑
HQY
88.73
+1.89%↑
PDCO
31.27
+0.06%↑
MDT
88.96
+0.59%↑
VEEV
226.47
-0.52%↓
A
115.98
+2.05%↑
HQY
88.73
+1.89%↑
PDCO
31.27
+0.06%↑
MDT
88.96
+0.59%↑
VEEV
226.47
-0.52%↓
A
115.98
+2.05%↑
HQY
88.73
+1.89%↑
PDCO
31.27
+0.06%↑
MDT
88.96
+0.59%↑
VEEV
226.47
-0.52%↓
A
115.98
+2.05%↑
HQY
88.73
+1.89%↑
PDCO
31.27
+0.06%↑
MDT
88.96
+0.59%↑
VEEV
226.47
-0.52%↓
A
115.98
+2.05%↑
HQY
88.73
+1.89%↑
PDCO
31.27
+0.06%↑
24h
Current
Min
268.22
Max
275.62
Income | -31M -152M |
---|---|
Sales | 126M 1.1B |
Profit margin | -13.467 |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +18.41% upside |
Next Earnings | 7 May 2025 |
---|
Market Cap | 22B |
---|---|
Previous open | 273.13 |
Previous close | 274.91 |
By Acuity
50%
50%
180 / 386 Healthcare
Past performance is not a reliable indicator of future results.
29 Jan 2025, 15:59 UTC
ImmunityBio Shares Rise After Collaboration, Supply Agreement With BeiGene
DJ
Read
27 Nov 2024, 15:22 UTC
BeiGene Shares Up on EU Approval for Gastric, Esophageal Cancer Treatment
DJ
Read
21 Nov 2024, 14:45 UTC
Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK
DJ
Read
22 Oct 2024, 18:39 UTC
Indaptus Therapeutics Shares Rise After Pact to Develop Cancer Treatment
DJ
Read
23 Apr 2024, 14:58 UTC
BeiGene Shares Rise 7% After European Approval of Tislelizumab Cancer Treatment
DJ
Read
27 Feb 2025, 11:07 UTC
BeiGene Sees 2025 Rev $4.9B-$5.3B >ONC
DJ
Read
27 Feb 2025, 11:06 UTC
BeiGene 4Q Global BRUKINSA Rev of $828M >ONC
DJ
Read
27 Feb 2025, 11:06 UTC
BeiGene 4Q Loss/Shr 11c >ONC
DJ
Read
27 Feb 2025, 11:06 UTC
BeiGene 4Q Rev $1.13B >ONC
DJ
Read
12 Nov 2024, 11:01 UTC
BeiGene 3Q Loss/Shr 9c >BGNE
DJ
Read
12 Nov 2024, 11:01 UTC
BeiGene 3Q Rev $1B >BGNE
DJ
Read
7 Aug 2024, 10:05 UTC
BeiGene 2Q Loss/Shr $1.15 >BGNE
DJ
Read
7 Aug 2024, 10:04 UTC
BeiGene 2Q Rev $929M >BGNE
DJ
Read
8 May 2024, 10:02 UTC
BeiGene 1Q Loss/Shr 19c >BGNE
DJ
Read
8 May 2024, 10:01 UTC
BeiGene 1Q Loss $251.2M >BGNE
DJ
Read
8 May 2024, 10:01 UTC
BeiGene 1Q Rev $752M >BGNE
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 320.95 USD 18.41%
High 359.47 USD
Low 259 USD
Based on 12 Wall Street analysts offering 12 month price targets forBeiGene Ltd ADR - Dist in the last 3 months.
By TipRanks
Strong Buy
12 ratings
11
Buy
1
Hold
0
Sell
Based on 12 analysts giving stock ratings to BeiGene Ltd ADR - Dist in the past 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Selling and administration expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Operating profit
$